Qualia Oto announced that its Board of Directors has appointed Benedict Voit as CEO. Voit brings a track record of strategic, financial, and operational leadership to the role. Since joining Qualia Oto in 2020, he has served as CFO and COO, helping to build the company's operational capabilities, strengthen its financing strategy, and advance development of its innovative cochlear implant technology platform.

The National Institute on Deafness and Other Communication Disorders (NIDCD) selected Qualia Oto as an award recipient for its Phase II Small Business Innovation Research (SBIR) program. This $1.84M award will fund two years of additional research and development as Qualia Oto solidifies a path toward commercialization and the securitization of an FDA Master File for its novel shape-adaptive polymer integration with cochlear implants (CIs).

From Chicago, IL to Warsaw, Poland, CMO Dr. Kenneth Lee represented Qualia Oto at two of the world’s most influential cochlear implant conferences of 2026: the American Cochlear Implant Alliance (ACIA) CI2026 Conference in Chicago, and CI2026 – the 18th International Conference on Cochlear Implants and Other Implantable Technologies – in Warsaw.